TABLE 2.
2010 American Association of Clinical Endocrinologists Protocol for Production of Clinical Practice Guidelines–Step II: Evidence Analysis and Subjective Factors
| Study design | Data analysis | Interpretation of results |
|---|---|---|
| Premise correctness | Intent-to-treat | Generalizability |
| Allocation concealment (randomization) | Appropriate statistics | Logical |
| Selection bias | Incompleteness | |
| Appropriate blinding | Validity | |
| Using surrogate end points (especially in “first-in-its-class” intervention) | ||
| Sample size (beta error) | ||
| Null hypothesis versus | ||
| Bayesian statistics |